Business Standard

Glaxosmithkline Pharmaceuticals Share Price

Know More
BSENSE

2,570.85 11.20 (0.44%)

12:00 AM,12th Jul 2024

2,570.70 21.10 (0.83%)

12:00 AM,12th Jul 2024

BSE : 500660

NSE : GLAXO

Sector : Health care

ISIN Code : INE159A01016

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 12-Jul-2024 | 12:00 AM IST

Market Cap (₹ Cr)

43,553

Turnover (₹ Cr)

0.22

Volume (Shares)

8,364

Face Value

10

52-WK High

2,759.00

52-WK High Date

14-Jun-2024

52-WK Low

1,376.50

52-WK Low Date

21-Jul-2023

All Time High

2,759.00

All Time High Date

14-Jun-2024

All Time Low

12.88

All Time Low Date

19-Aug-1988

Glaxosmithkline Pharmaceuticals Ltd

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc. a global biopharma company to unite science technology and talent to get ahead of disease together. The Company is headquartered in Mumbai and it has six branch offices a manufacturing facility at Nashik in Maharashtra 22 contract manufacturing organisations (CMOs) with regional and sales hubs across India. The Company is engaged interalia in the business of manufacturing distributing and trading in pharmaceuticals.The Company's portfolio includes General Medicines Vaccines and Specialty medicines that help prevent and treat disease. Their prescription medicines range across therapeutic areas such as Anti-Infectives...
Read More

Glaxosmithkline Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

43,550

EPS - TTM (₹) [C]

38.76

P/E Ratio (X) [C]

24.50

Face Value (₹) 10
Latest Dividend (%)320.00
Latest Dividend Date 31-May-2024
Dividend Yield (%) 1.24
Book Value Share (₹) [C]104.93
P/B Ratio (₹) [C]24.50

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Aditya Birla SL ELSS Tax Saver Fund (IDCW) 279.23 10,53,316 1.71
Aditya Birla SL ELSS Tax Saver Fund (G) 279.23 10,53,316 1.71
Aditya Birla SL ELSS Tax Saver Fund - Direct (IDCW) 279.23 10,53,316 1.71
Aditya Birla SL ELSS Tax Saver Fund - Direct (G) 279.23 10,53,316 1.71
Kotak Equity Opportunities (G) 249.64 9,41,665 1.04
Kotak Equity Opportunities (IDCW) 249.64 9,41,665 1.04
Kotak Equity Opportunities - Direct (G) 249.64 9,41,665 1.04
Nippon India Pharma Fund (G) 220.77 8,32,787 2.98
Nippon India Pharma Fund (Bonus) 220.77 8,32,787 2.98
Nippon India Pharma Fund (IDCW) 220.77 8,32,787 2.98

Load more

Research Reports

Date Broker Action Prices(₹) Report
26-Aug-2022Nirmal Bang Not Rated 1,463

Stock Strength

Today's Low/High

2,540.60

2,619.90

Week Low/High

2,501.00

2,620.00

Month Low/High

2,499.55

2,760.00

Year Low/High

1,377.25

2,760.00

All time Low/High

12.88

2,760.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week1.40%1.26%0.650.73%
1 Month-2.17%-2.09%5.115.06%
3 Month36.45%36.64%8.458.80%
6 Month13.91%13.90%10.9611.91%
1 Year84.39%84.29%23.1326.40%
3 Year71.73%71.83%53.7456.14%

Company Info

Company Information

Independent Director : D Sundaram

Company Sec. & Compli. Officer : A A Nadkarni

Independent Director : P V Bhide

Independent Director : A N Roy

Non Executive Director : Subesh Williams

Chairperson : Renu S Karnad

Independent Director : Sunita Maheshwari

Independent Director : Manu Anand

Managing Director : Bhushan Akshikar

Whole Time Director & CFO : J. Chandy

Registered Office: GSK House, Dr Annie Besant Road Worli,Mumbai,Maharashtra-400030 Ph: 91-022-24959595

Email:askus@gsk.com; ajay.a.nadkarni@gsk.com

URL:http://www.gsk-india.com

FAQs about Glaxosmithkline Pharmaceuticals Ltd

1. What's the Glaxosmithkline Pharmaceuticals Ltd share price today?
Glaxosmithkline Pharmaceuticals Ltd share price was Rs 2,570.85 at close on 12th Jul 2024. Glaxosmithkline Pharmaceuticals Ltd share price was up by 0.44% over the previous closing price of Rs 2,559.65. Glaxosmithkline Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Glaxosmithkline Pharmaceuticals Ltd share price moved down by 2.17% on BSE
  • Last 3 Months: Glaxosmithkline Pharmaceuticals Ltd share price moved up by 36.45% on BSE
  • Last 12 Months: Glaxosmithkline Pharmaceuticals Ltd share price moved up by 84.39% on BSE
  • Last 3 Years: Glaxosmithkline Pharmaceuticals Ltd price moved up by 71.73% on BSE


2. How can I quickly analyse the performance of the Glaxosmithkline Pharmaceuticals Ltd stock?
The performance of the Glaxosmithkline Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 66.32
  • Price to book value ratio is 24.50
  • Dividend yield of 1.24
  • The EPS (trailing 12 months) of the Glaxosmithkline Pharmaceuticals Ltd stock is Rs 38.76


3. What is the market cap of Glaxosmithkline Pharmaceuticals Ltd?
Glaxosmithkline Pharmaceuticals Ltd has a market capitalisation of Rs 43,553 crore.


4. What is Glaxosmithkline Pharmaceuticals Ltd's 52-week high/low share price?
The Glaxosmithkline Pharmaceuticals Ltd’s 52-week high share price is Rs 2,759.00 and 52-week low share price is Rs 1,376.50.


5. Is the Glaxosmithkline Pharmaceuticals Ltd profitable?
On a consolidated basis, Glaxosmithkline Pharmaceuticals Ltd reported a profit of Rs 193.08 crore on a total income of Rs 943.14 crore for the quarter ended 2024. For the year ended Mar 2024, Glaxosmithkline Pharmaceuticals Ltd had posted a profit of Rs 194.48 crore on a total income of Rs 962.03 crore.


6. Which are Glaxosmithkline Pharmaceuticals Ltd’s peers in the Health care sector?
Glaxosmithkline Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Aurobindo Pharma, Alkem Lab, Abbott India, Glaxosmi. Pharma, Biocon, Glenmark Pharma., Gland Pharma.


7. Who owns how much in Glaxosmithkline Pharmaceuticals Ltd?
Key changes to the Glaxosmithkline Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Glaxosmithkline Pharmaceuticals Ltd has gone up to 75.00 per cent as of Jun 2024 from 75.00 per cent as of Sep 2023.